Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions
NCT00829894 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2024-08-19
Summary
The objective of this study was to compare the rate and extent of absorption of risperidone 1 mg tablets (test) versus Risperdal® (reference) administered as a 1 x 1 mg tablets under fed conditions.
Conditions
- Healthy
Interventions
- DRUG
-
Risperidone
1 mg Tablet
- DRUG
-
Risperidone
1 mg Tablet
Sponsors & Collaborators
-
Teva Pharmaceuticals USA
lead INDUSTRY
Principal Investigators
-
Benoit Girard, MD · Anapharm
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-06-30
- Primary Completion
- 2001-07-31
- Completion
- 2001-07-31
Countries
- Canada
Study Locations
More Related Trials
-
Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
NCT01155921 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
NCT00249223 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
NCT00246259 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
NCT00249236 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Bioavailability of Risperidone.
NCT05179525 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia
NCT00998608 ·Status: TERMINATED ·Phase: PHASE4
-
An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
NCT01894984 ·Status: TERMINATED
-
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
NCT00253162 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
NCT00558298 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
NCT00253136 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
NCT00253149 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
NCT00240708 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of LY03004 and Risperdal® Consta®
NCT02091388 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Volunteers
NCT01708616 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
NCT00257075 ·Status: COMPLETED ·Phase: PHASE3
-
A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
NCT00698022 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
NCT00246246 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection
NCT00236548 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
NCT00216580 ·Status: COMPLETED ·Phase: PHASE3
-
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
NCT00458367 ·Status: COMPLETED
-
Risperidone and Suicidality in Major Depressive Disorder
NCT00167154 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
NCT00250367 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia
NCT00236587 ·Status: COMPLETED ·Phase: PHASE3
-
A Bioequivalence Study of 15 mg ER OROS Paliperidone
NCT00892489 ·Status: COMPLETED ·Phase: PHASE1
-
Different Safety Profile of Risperidone and Paliperidone Extended-release
NCT01284959 ·Status: COMPLETED ·Phase: PHASE4